Process R&D is vital in the development of pharmaceuticals and therapies yet more and more companies are being put under pressure to reduce time, costs and risk associated with process R&D to make treatments widely available and accessible to patients. In this article, Maria Andrielou, marketing & communication, and Thanos Andreou, scientific affairs, at VIO Chemicals, give their views on how to get the best out of process R&D.
Under pressure
Pharmaceutical process research and development (R&D) is indispensable in the development of personalised medicines and innovative treatments that deal effectively with diseases. In order to make treatments widely available and accessible to patients, the pressure to demonstrate improved outcomes at lower costs is getting higher. This is particularly true when Europe faces increasing competition from emerging economies, such as Brazil and China.1